Started in the lab with a PhD in molecular medicine, pioneering single-cell technologies in cardiac regeneration at Stanford University, Charité Berlin, and Goethe University Frankfurt, then moved into BioPharma consulting, supporting 15+ clients across preclinical and clinical development and screening over 500 assets. Now focused on investing at the Pre-Seed and Seed stage at Pace Ventures, backing exceptional scientists building the next wave of Bio x Health innovation across the US and Europe. Also, supporting the startup ecosystem as an advisor at the BII by Novo Nordisk, Nucleate, and Spark.